Newborn affected by noxious substances transmitted via placenta or breast milk
Chapter 16:Certain conditions originating in the perinatal period
ICD-10 P04 is a billable code used to indicate a diagnosis of newborn affected by noxious substances transmitted via placenta or breast milk.
The ICD-10 code P04 is used to classify newborns who are affected by noxious substances that have been transmitted through the placenta or breast milk. This condition often arises from maternal substance use, including drugs, alcohol, and tobacco during pregnancy or lactation. Newborns exposed to these substances may present with a range of symptoms, including withdrawal symptoms, developmental delays, and various physical abnormalities. The impact of these substances can lead to complications such as low birth weight, respiratory distress, and neurodevelopmental issues. Accurate coding is crucial for appropriate management and follow-up care, as well as for understanding the long-term implications for the child. Documentation should include maternal history, substance use details, and any observed neonatal symptoms to ensure proper coding and care planning.
Neonatal documentation must include detailed assessments of withdrawal symptoms, growth parameters, and any interventions provided.
Common scenarios include infants presenting with NAS (Neonatal Abstinence Syndrome) requiring pharmacological treatment or supportive care in the NICU.
Consideration must be given to the timing of maternal substance use and the potential for long-term developmental follow-up.
Pediatric documentation should reflect ongoing assessments of developmental milestones and any behavioral concerns related to prenatal exposure.
Pediatric scenarios may involve monitoring for developmental delays or behavioral issues in children with a history of prenatal substance exposure.
Pediatricians should be aware of the potential for co-occurring conditions and the need for interdisciplinary care.
Used in conjunction with P04 when assessing a newborn affected by noxious substances.
Documentation must include a thorough assessment of the newborn's condition and any interventions.
Neonatologists should ensure that all aspects of care related to substance exposure are documented.
Common symptoms include irritability, feeding difficulties, tremors, seizures, and respiratory distress. Each substance may present with unique symptoms, necessitating thorough assessment.
